Reaktionsgleichung
[N:1]1[CH:6]=[CH:5][C:4](=O)[NH:3][CH:2]=1.[Cl:8][C:9]1[C:14](I)=[CH:13]N=CN=1.Cl.[CH:17]([O:20][C:21](=[O:31])[C@H:22]([CH2:24][C:25]1[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=1)[NH2:23])([CH3:19])[CH3:18]>>[ClH:8].[CH:17]([O:20][C:21](=[O:31])[C@H:22]([CH2:24][C:25]1[CH:26]=[CH:27][CH:28]=[CH:29][CH:30]=1)[NH2:23])([CH3:19])[CH3:18].[CH:17]([O:20][C:21](=[O:31])[C@H:22]([CH2:24][C:25]1[CH:26]=[CH:27][CH:28]=[CH:29][CH:30]=1)[NH:23][C:4]1[C:5]([CH2:13][CH2:14][C:9]2[CH:26]=[CH:25][CH:24]=[CH:22][CH:21]=2)=[CH:6][N:1]=[CH:2][N:3]=1)([CH3:19])[CH3:18]Komponenten
5
Edukt 3
Produkt 2
Versuchsvorschrift
L-Phenylalanine isopropyl ester hydrochloride was prepared by Method LLL. 4(3H)-Pyrimidinone (Aldrich) was sequentially converted via Methods N and O to 4-chloro-5-iodopyrimidine. L-Phenylalanine isopropyl ester hydrochloride and 4-chloro-5-iodopyrimidine were coupled via Method P and the coupled product sequentially converted via Methods OOO and X to give the title compound.
Quellen und Nachweise
- ORD-Eintrag
- ord-85cef34de15946eea65b444b4a602201
- Quelldatensatz
- uspto-grants-2006_02
- Patentnummer
- US07005433B2
Verknüpfte Notizen
Wird geladen…